Histone Deacetylase (HDAC) inhibitors as potential anticancer drugs in Neuroendocrine Carcinomas (NEC) of cervix and endometrium

被引：0
|
作者：
Rito, M. [1 ]
Silva, F. [1 ]
Felix, A. [1 ]
机构：
[1] IPO Lisboa Francisco Gentil, Serv Anat Patol, Lisbon, Portugal
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-05-005
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [1] The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
    Vaca, Hugo R.
    Celentano, Ana M.
    Agustina Toscanini, Maria
    Heimburg, Tino
    Ghazy, Ehab
    Zeyen, Patrik
    Hauser, Alexander-Thomas
    Oliveira, Guilherme
    Elissondo, Maria C.
    Jung, Manfred
    Sippl, Wolfgang
    Camicia, Federico
    Cecilia Rosenzvit, Mara
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
  • [2] Histone Deacetylase Inhibitors as Anticancer Drugs
    Eckschlager, Tomas
    Plch, Johana
    Stiborova, Marie
    Hrabeta, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [3] Amphiphilic polycaprolactone block copolymers containing conjugated histone deacetylase inhibitors for delivery of anticancer drugs and HDAC inhibitors
    Senevirathne, Suchithra A.
    Hao, Jing
    Biewer, Michael C.
    Stefan, Mihaela C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [4] Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent
    Patel, Preeti
    Wahan, Simranpreet K.
    Vishakha, S.
    Das Kurmi, Balak
    Das Gupta, Ghanshyam
    Rajak, Harish
    Asati, Vivek
    CURRENT CANCER DRUG TARGETS, 2023, 23 (01) : 47 - 70
  • [5] Novel HDAC Inhibitors as Potential Anticancer Drugs
    Sanchez-Michael, Laura
    Quesada, Gabriela Torres
    Gutierrez, Denisse
    Varela-Ramirez, Armando
    Vijayalaxmi, S.
    Karki, Subhas
    Aguilera, Renato
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S210 - S210
  • [6] Anticancer properties of histone deacetylase inhibitors - what is their potential?
    Kielbowski, Kajetan
    Szwedkowicz, Agata
    Plewa, Paulina
    Bakinowska, Estera
    Becht, Rafal
    Pawlik, Andrzej
    EXPERT REVIEW OF ANTICANCER THERAPY, 2025, 25 (02) : 105 - 120
  • [7] The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
    Marks, Paul A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (09) : 1049 - 1066
  • [8] Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
    Sarkar, Rajat
    Banerjee, Suvankar
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 192
  • [9] Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
    Ghazy, Ehab
    Abdelsalam, Mohamed
    Robaa, Dina
    Pierce, Raymond J.
    Sippl, Wolfgang
    PHARMACEUTICALS, 2022, 15 (01)
  • [10] Anticancer activities of histone deacetylase inhibitors
    Jessica E. Bolden
    Melissa J. Peart
    Ricky W. Johnstone
    Nature Reviews Drug Discovery, 2006, 5 : 769 - 784
12345